Global Cord Blood Corporation
CORBF
$1.02
-$0.13-11.30%
| 03/31/2022 | 09/30/2021 | 03/31/2021 | 12/31/2020 | ||
|---|---|---|---|---|---|
| Revenue | 46.82M | 48.48M | 46.63M | 43.90M | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 46.82M | 48.48M | 46.63M | 43.90M | |
| Cost of Revenue | 6.61M | 7.14M | 7.08M | 6.78M | |
| Gross Profit | 40.21M | 41.33M | 39.55M | 37.13M | |
| SG&A Expenses | 17.06M | 15.68M | 15.84M | 17.06M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 24.43M | 23.68M | 23.76M | 25.19M | |
| Operating Income | 22.39M | 24.80M | 22.86M | 18.71M | |
| Income Before Tax | 22.06M | 24.17M | 23.86M | 21.04M | |
| Income Tax Expenses | 5.24M | 4.37M | 3.77M | 3.20M | |
| Earnings from Continuing Operations | 16.82M | 19.80M | 20.10M | 17.84M | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -328.00K | -371.80K | -395.90K | -239.60K | |
| Net Income | 16.50M | 19.43M | 19.70M | 17.60M | |
| EBIT | 22.39M | 24.80M | 22.86M | 18.71M | |
| EBITDA | 24.28M | 26.49M | 24.76M | 20.58M | |
| EPS Basic | 0.14 | 0.16 | 0.16 | 0.14 | |
| Normalized Basic EPS | 0.12 | 0.13 | 0.12 | -- | |
| EPS Diluted | 0.14 | 0.16 | 0.16 | 0.14 | |
| Normalized Diluted EPS | 0.12 | 0.13 | 0.12 | -- | |
| Average Basic Shares Outstanding | 121.76M | 121.55M | 121.65M | 121.43M | |
| Average Diluted Shares Outstanding | 121.76M | 121.55M | 121.65M | 121.43M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |
